Global Colorectal Cancer Diagnostics & Therapeutics Market Size, Status and Forecast 2021-2027

結腸直腸がん診断・治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Colorectal Cancer Diagnostics & Therapeutics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR1452
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:127
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥429,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥643,500見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥858,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、結腸直腸がん診断・治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(結腸直腸がん診断、結腸直腸がん治療)、用途別市場規模(病院、専門クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・結腸直腸がん診断・治療の市場動向
・企業の競争状況、市場シェア
・結腸直腸がん診断・治療の種類別市場規模(結腸直腸がん診断、結腸直腸がん治療)
・結腸直腸がん診断・治療の用途別市場規模(病院、専門クリニック、その他)
・結腸直腸がん診断・治療の北米市場規模2016-2027(アメリカ、カナダ)
・結腸直腸がん診断・治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・結腸直腸がん診断・治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・結腸直腸がん診断・治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・結腸直腸がん診断・治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Biocept、Cancer Genetics、Foundation Medicine、Sysmex Corporation、Danaher Corporation、Epigenomics、Illumina、Rosetta Genomics、Exact Science Corporation、Pathway Genomics Corporation、Taiho Pharma、Merck KGaA、Amgen、Takeda、Roche、Eli Lilly、Sanofi、Regeneron、Bayer、Onyx)
・結論

Market Analysis and Insights: Global Colorectal Cancer Diagnostics & Therapeutics Market
The global Colorectal Cancer Diagnostics & Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colorectal Cancer Diagnostics & Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colorectal Cancer Diagnostics & Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colorectal Cancer Diagnostics & Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colorectal Cancer Diagnostics & Therapeutics market.

Global Colorectal Cancer Diagnostics & Therapeutics Scope and Market Size
Colorectal Cancer Diagnostics & Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Diagnostics & Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Colorectal Cancer Diagnostics
Colorectal Cancer Therapeutics

Segment by Application
Hospitals
Specialty Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biocept
Cancer Genetics
Foundation Medicine
Sysmex Corporation
Danaher Corporation
Epigenomics
Illumina
Rosetta Genomics
Exact Science Corporation
Pathway Genomics Corporation
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Colorectal Cancer Diagnostics
1.2.3 Colorectal Cancer Therapeutics
1.3 Market by Application
1.3.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Perspective (2016-2027)
2.2 Colorectal Cancer Diagnostics & Therapeutics Growth Trends by Regions
2.2.1 Colorectal Cancer Diagnostics & Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Colorectal Cancer Diagnostics & Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Colorectal Cancer Diagnostics & Therapeutics Industry Dynamic
2.3.1 Colorectal Cancer Diagnostics & Therapeutics Market Trends
2.3.2 Colorectal Cancer Diagnostics & Therapeutics Market Drivers
2.3.3 Colorectal Cancer Diagnostics & Therapeutics Market Challenges
2.3.4 Colorectal Cancer Diagnostics & Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Revenue
3.1.1 Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Diagnostics & Therapeutics Revenue
3.4 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Diagnostics & Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2020
3.5 Colorectal Cancer Diagnostics & Therapeutics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Diagnostics & Therapeutics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Diagnostics & Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Type
4.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Type (2022-2027)

5 Colorectal Cancer Diagnostics & Therapeutics Breakdown Data by Application
5.1 Global Colorectal Cancer Diagnostics & Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size (2016-2027)
6.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
6.2.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2027)
6.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
6.3.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2027)
6.4 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
6.4.1 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size (2016-2027)
7.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
7.2.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2027)
7.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
7.3.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2027)
7.4 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
7.4.1 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
8.2.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
8.3.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region
8.4.1 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size (2016-2027)
9.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
9.2.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
9.3.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
9.4.1 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type
10.2.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application
10.3.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country
10.4.1 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biocept
11.1.1 Biocept Company Details
11.1.2 Biocept Business Overview
11.1.3 Biocept Colorectal Cancer Diagnostics & Therapeutics Introduction
11.1.4 Biocept Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.1.5 Biocept Recent Development
11.2 Cancer Genetics
11.2.1 Cancer Genetics Company Details
11.2.2 Cancer Genetics Business Overview
11.2.3 Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.2.4 Cancer Genetics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.2.5 Cancer Genetics Recent Development
11.3 Foundation Medicine
11.3.1 Foundation Medicine Company Details
11.3.2 Foundation Medicine Business Overview
11.3.3 Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Introduction
11.3.4 Foundation Medicine Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.3.5 Foundation Medicine Recent Development
11.4 Sysmex Corporation
11.4.1 Sysmex Corporation Company Details
11.4.2 Sysmex Corporation Business Overview
11.4.3 Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.4.4 Sysmex Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.4.5 Sysmex Corporation Recent Development
11.5 Danaher Corporation
11.5.1 Danaher Corporation Company Details
11.5.2 Danaher Corporation Business Overview
11.5.3 Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.5.4 Danaher Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.5.5 Danaher Corporation Recent Development
11.6 Epigenomics
11.6.1 Epigenomics Company Details
11.6.2 Epigenomics Business Overview
11.6.3 Epigenomics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.6.4 Epigenomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.6.5 Epigenomics Recent Development
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Colorectal Cancer Diagnostics & Therapeutics Introduction
11.7.4 Illumina Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.7.5 Illumina Recent Development
11.8 Rosetta Genomics
11.8.1 Rosetta Genomics Company Details
11.8.2 Rosetta Genomics Business Overview
11.8.3 Rosetta Genomics Colorectal Cancer Diagnostics & Therapeutics Introduction
11.8.4 Rosetta Genomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.8.5 Rosetta Genomics Recent Development
11.9 Exact Science Corporation
11.9.1 Exact Science Corporation Company Details
11.9.2 Exact Science Corporation Business Overview
11.9.3 Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.9.4 Exact Science Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.9.5 Exact Science Corporation Recent Development
11.10 Pathway Genomics Corporation
11.10.1 Pathway Genomics Corporation Company Details
11.10.2 Pathway Genomics Corporation Business Overview
11.10.3 Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Introduction
11.10.4 Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.10.5 Pathway Genomics Corporation Recent Development
11.11 Taiho Pharma
11.11.1 Taiho Pharma Company Details
11.11.2 Taiho Pharma Business Overview
11.11.3 Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Introduction
11.11.4 Taiho Pharma Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.11.5 Taiho Pharma Recent Development
11.12 Merck KGaA
11.12.1 Merck KGaA Company Details
11.12.2 Merck KGaA Business Overview
11.12.3 Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Introduction
11.12.4 Merck KGaA Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.12.5 Merck KGaA Recent Development
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Colorectal Cancer Diagnostics & Therapeutics Introduction
11.13.4 Amgen Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.13.5 Amgen Recent Development
11.14 Takeda
11.14.1 Takeda Company Details
11.14.2 Takeda Business Overview
11.14.3 Takeda Colorectal Cancer Diagnostics & Therapeutics Introduction
11.14.4 Takeda Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.14.5 Takeda Recent Development
11.15 Roche
11.15.1 Roche Company Details
11.15.2 Roche Business Overview
11.15.3 Roche Colorectal Cancer Diagnostics & Therapeutics Introduction
11.15.4 Roche Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.15.5 Roche Recent Development
11.16 Eli Lilly
11.16.1 Eli Lilly Company Details
11.16.2 Eli Lilly Business Overview
11.16.3 Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Introduction
11.16.4 Eli Lilly Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.16.5 Eli Lilly Recent Development
11.17 Sanofi
11.17.1 Sanofi Company Details
11.17.2 Sanofi Business Overview
11.17.3 Sanofi Colorectal Cancer Diagnostics & Therapeutics Introduction
11.17.4 Sanofi Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.17.5 Sanofi Recent Development
11.18 Regeneron
11.18.1 Regeneron Company Details
11.18.2 Regeneron Business Overview
11.18.3 Regeneron Colorectal Cancer Diagnostics & Therapeutics Introduction
11.18.4 Regeneron Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.18.5 Regeneron Recent Development
11.18 Bayer
.1 Bayer Company Details
.2 Bayer Business Overview
.3 Bayer Colorectal Cancer Diagnostics & Therapeutics Introduction
.4 Bayer Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
.5 Bayer Recent Development
11.20 Onyx
11.20.1 Onyx Company Details
11.20.2 Onyx Business Overview
11.20.3 Onyx Colorectal Cancer Diagnostics & Therapeutics Introduction
11.20.4 Onyx Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
11.20.5 Onyx Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Colorectal Cancer Diagnostics
Table 3. Key Players of Colorectal Cancer Therapeutics
Table 4. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Regions (2022-2027)
Table 10. Colorectal Cancer Diagnostics & Therapeutics Market Trends
Table 11. Colorectal Cancer Diagnostics & Therapeutics Market Drivers
Table 12. Colorectal Cancer Diagnostics & Therapeutics Market Challenges
Table 13. Colorectal Cancer Diagnostics & Therapeutics Market Restraints
Table 14. Global Colorectal Cancer Diagnostics & Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2020)
Table 17. Ranking of Global Top Colorectal Cancer Diagnostics & Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Colorectal Cancer Diagnostics & Therapeutics Product Solution and Service
Table 21. Date of Enter into Colorectal Cancer Diagnostics & Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Colorectal Cancer Diagnostics & Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Colorectal Cancer Diagnostics & Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Biocept Company Details
Table 62. Biocept Business Overview
Table 63. Biocept Colorectal Cancer Diagnostics & Therapeutics Product
Table 64. Biocept Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Biocept Recent Development
Table 66. Cancer Genetics Company Details
Table 67. Cancer Genetics Business Overview
Table 68. Cancer Genetics Colorectal Cancer Diagnostics & Therapeutics Product
Table 69. Cancer Genetics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Cancer Genetics Recent Development
Table 71. Foundation Medicine Company Details
Table 72. Foundation Medicine Business Overview
Table 73. Foundation Medicine Colorectal Cancer Diagnostics & Therapeutics Product
Table 74. Foundation Medicine Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Foundation Medicine Recent Development
Table 76. Sysmex Corporation Company Details
Table 77. Sysmex Corporation Business Overview
Table 78. Sysmex Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 79. Sysmex Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Sysmex Corporation Recent Development
Table 81. Danaher Corporation Company Details
Table 82. Danaher Corporation Business Overview
Table 83. Danaher Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 84. Danaher Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Danaher Corporation Recent Development
Table 86. Epigenomics Company Details
Table 87. Epigenomics Business Overview
Table 88. Epigenomics Colorectal Cancer Diagnostics & Therapeutics Product
Table 89. Epigenomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Epigenomics Recent Development
Table 91. Illumina Company Details
Table 92. Illumina Business Overview
Table 93. Illumina Colorectal Cancer Diagnostics & Therapeutics Product
Table 94. Illumina Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Illumina Recent Development
Table 96. Rosetta Genomics Company Details
Table 97. Rosetta Genomics Business Overview
Table 98. Rosetta Genomics Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Rosetta Genomics Recent Development
Table 100. Exact Science Corporation Company Details
Table 101. Exact Science Corporation Business Overview
Table 102. Exact Science Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 103. Exact Science Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Exact Science Corporation Recent Development
Table 105. Pathway Genomics Corporation Company Details
Table 106. Pathway Genomics Corporation Business Overview
Table 107. Pathway Genomics Corporation Colorectal Cancer Diagnostics & Therapeutics Product
Table 108. Pathway Genomics Corporation Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Pathway Genomics Corporation Recent Development
Table 110. Taiho Pharma Company Details
Table 111. Taiho Pharma Business Overview
Table 112. Taiho Pharma Colorectal Cancer Diagnostics & Therapeutics Product
Table 113. Taiho Pharma Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Taiho Pharma Recent Development
Table 115. Merck KGaA Company Details
Table 116. Merck KGaA Business Overview
Table 117. Merck KGaA Colorectal Cancer Diagnostics & Therapeutics Product
Table 118. Merck KGaA Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Merck KGaA Recent Development
Table 120. Amgen Company Details
Table 121. Amgen Business Overview
Table 122. Amgen Colorectal Cancer Diagnostics & Therapeutics Product
Table 123. Amgen Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Amgen Recent Development
Table 125. Takeda Company Details
Table 126. Takeda Business Overview
Table 127. Takeda Colorectal Cancer Diagnostics & Therapeutics Product
Table 128. Takeda Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Takeda Recent Development
Table 130. Roche Company Details
Table 131. Roche Business Overview
Table 132. Roche Colorectal Cancer Diagnostics & Therapeutics Product
Table 133. Roche Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 134. Roche Recent Development
Table 135. Eli Lilly Company Details
Table 136. Eli Lilly Business Overview
Table 137. Eli Lilly Colorectal Cancer Diagnostics & Therapeutics Product
Table 138. Eli Lilly Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 139. Eli Lilly Recent Development
Table 140. Sanofi Company Details
Table 141. Sanofi Business Overview
Table 142. Sanofi Colorectal Cancer Diagnostics & Therapeutics Product
Table 143. Sanofi Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 144. Sanofi Recent Development
Table 145. Regeneron Company Details
Table 146. Regeneron Business Overview
Table 147. Regeneron Colorectal Cancer Diagnostics & Therapeutics Product
Table 148. Regeneron Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 149. Regeneron Recent Development
Table 150. Bayer Company Details
Table 151. Bayer Business Overview
Table 152. Bayer Colorectal Cancer Diagnostics & Therapeutics Product
Table 153. Bayer Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 154. Bayer Recent Development
Table 155. Onyx Company Details
Table 156. Onyx Business Overview
Table 157. Onyx Colorectal Cancer Diagnostics & Therapeutics Product
Table 158. Onyx Revenue in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021) & (US$ Million)
Table 159. Onyx Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Colorectal Cancer Diagnostics Features
Figure 3. Colorectal Cancer Therapeutics Features
Figure 4. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Specialty Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Colorectal Cancer Diagnostics & Therapeutics Report Years Considered
Figure 9. Global Colorectal Cancer Diagnostics & Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Colorectal Cancer Diagnostics & Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Colorectal Cancer Diagnostics & Therapeutics Market Share by Players in 2020
Figure 14. Global Top Colorectal Cancer Diagnostics & Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Diagnostics & Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Colorectal Cancer Diagnostics & Therapeutics Revenue in 2020
Figure 16. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Colorectal Cancer Diagnostics & Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Colorectal Cancer Diagnostics & Therapeutics Market Share by Region (2016-2027)
Figure 38. China Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Colorectal Cancer Diagnostics & Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Colorectal Cancer Diagnostics & Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Biocept Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 58. Cancer Genetics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 59. Foundation Medicine Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 60. Sysmex Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 61. Danaher Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 62. Epigenomics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 63. Illumina Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 64. Rosetta Genomics Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 65. Exact Science Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 66. Pathway Genomics Corporation Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 67. Taiho Pharma Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 68. Merck KGaA Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 69. Amgen Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 70. Takeda Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 71. Roche Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 72. Eli Lilly Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 73. Sanofi Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 74. Regeneron Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 75. Bayer Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 76. Onyx Revenue Growth Rate in Colorectal Cancer Diagnostics & Therapeutics Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[結腸直腸がん診断・治療の世界市場規模・現状・予測2021年-2027年] (Global Colorectal Cancer Diagnostics & Therapeutics Market Size, Status and Forecast 2021-2027 / QY21APR1452)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆